Skip to main content

Ribon Therapeutics

Cambridge, United States

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

$25.0M raised
Dec 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ribon Therapeutics

How much funding has Ribon Therapeutics raised?
Ribon Therapeutics has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.
Who are Ribon Therapeutics's investors?
Ribon Therapeutics's investors include AbbVie, U.S. Venture Partners, The Column Group, Johnson & Johnson Innovation, Google Ventures.
Where is Ribon Therapeutics headquartered?
Ribon Therapeutics is headquartered in Cambridge, United States.
What does Ribon Therapeutics do?
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
What stage is Ribon Therapeutics at?
Ribon Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ribon Therapeutics — Funding & Investors." VCBacked, December 22, 2022, https://www.vcbacked.co/company/ribon-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Ribon Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ribon-therapeutics
Wikipedia (cite web)
{{cite web |title=Ribon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ribon-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .